Cerebrolysin: all 34 studies that test it
Page 1 of 1. Open to participants first (10), then studies with results posted, then the rest; newest registration first within each.
- Combined Acupuncture-Based Therapy for Rehabilitation After Ischemic StrokeNot yet recruitingNCT07846488Not applicable
- Cerebrolysin in Critically Ill Patients With DeliriumEnrolling by invitationNCT06677502Not applicable
- Cerebrolysin as an Add-On Therapy to Standard Treatment of Basilar Artery OcclusionNot yet recruitingNCT06489925Early Phase 1
- Cerebrolysin After Reperfusion in Extended-window EndoVascular ThrombectomyNot yet recruitingNCT06339411Phase 2
- Effect of Cerebrolysin on the Blood Brain Barrier in Patients With Diabetes and Ischemic StrokeRecruitingNCT06273020Phase 4
- CERebrolysine Effect on Blood-brain Barrier in acUte Ischemic StrokeRecruitingNCT06078215Phase 4
- A Prospective, Trial About Safety and Efficacy of Combined Treatment With Cerebrolysin in Acute Ischemic Hemispheric Stroke Patients Undergoing EndoVascular Treatment (EVT)RecruitingNCT06070753Not applicable
- Cerebrolysin in Prevention of Postoperative Delirium in Cardiac SurgeryEnrolling by invitationNCT05864677Not applicable
- Efficacy of Prednisolone Versus Cerebrolysin in the Treatment of Bell's PalsyRecruitingNCT05821075Phase 1/2
- Efficacy and Safety of Cerebrolysin on Prolonged Disorders of ConsciousnessRecruitingNCT04427241Phase 4
- Dl-3-n-butylphthalide and Cerebrolysin Treatment in Acute Ischemic StrokeCompletedNCT02149875Phase 1/2Results posted
- A Clinical Trial to Evaluate the Safety and Efficacy of 20 ml Cerebrolysin in Patients With Vascular DementiaCompletedNCT00947531Phase 4Results posted
- Comparative Study to Test Safety and Efficacy of Neurotrophic and Cholinergic Treatment of Alzheimer's DiseaseCompletedNCT00911807Phase 2Results posted
- Clinical Characteristics and Treatment of Anosmia and Ageusia Due to SARS-CoV2 VariantsCompletedNCT06208540Phase 4
- Combined Cerebrolysin and Amantadine Sulfate Administration for Patients With Traumatic Brain Injury in the ICUCompletedNCT06052787Phase 3
- CERebrolysin in CADASILActive, not recruitingNCT05755997Phase 2
- Hair Repigmentation During Cerebrolysin TherapyCompletedNCT05288465Not applicable
- Early Administration of Cerebrolysin on the Outcome of Patients With Acute Stroke Undergoing EVTStatus unknownNCT05124353Phase 2/3
- Effects of Cerebrolysin on Level of Consciousness and Brain Metabolism in Disorder of Consciousness After Stroke: Single Center Randomized Controlled StudyStatus unknownNCT04913831Phase 4
- Efficacy of Cerebrolysin Treatment as an add-on Therapy to Mechanical Thrombectomy in Acute Ischemic Stroke.Status unknownNCT04904341Phase 3
- Cerebrolycin for Treatment of Covid-related Anosmia and AgeusiaCompletedNCT04830943Phase 3
- the Effect of Cerebrolysin on Physical and Mental Functions of Down SyndromeCompletedNCT04751136Phase 2
- IMPULSE - StIMulation of Brain Plasticity to Improve Upper Limb Recovery After StrokETerminatedNCT04124367Phase 2
- Cerebrolysin and Neurodevelopment in Preterm InfantsCompletedNCT03506841Phase 1
- Effects of Cerebrolysin Combined With Rehabilitation on Motor Recovery in StrokeCompletedNCT02768571Phase 4
- Comprehensive Reparative Therapy in Ischemic Stroke COMplex Repair in Ischemic Stroke-ArmStatus unknownNCT02581371Phase 4
- Cerebrolysin Neural Repair Therapy in Children With Traumatic Brain Injury and Cerebral PalsyStatus unknownNCT02116348Phase 2
- Effects of Cerebrolysin on Motor Recovery in Patients With Subacute StrokeCompletedNCT01996761Phase 4
- Cerebrolysin Compared to Donepezil in Patients With Mild to Moderate Dementia of Alzheimer's Type (DAT)WithdrawnNCT01822951Phase 4
- The CAPTAIN Trial: Cerebrolysin Asian Pacific Trial in Acute Brain Injury and NeurorecoveryTerminatedNCT01606111Phase 4
- Navigation Brain Stimulation for Evaluation of the Neuroprotective Drug Efficiency in Patients After Ischemic Stroke.CompletedNCT01388738Phase 3
- Study of Cerebrolysin for Treatment of Infants With History of Neonatal Hypoxic Ischemic EncephalopathyCompletedNCT01059461Phase 2
- The Safety and Efficacy of Cerebrolysin in Patients With Acute Ischemic StrokeCompletedNCT00868283Phase 4
- Combined Treatment With Alteplase (Rt-PA) and Cerebrolysin® in Acute Ischemic Hemispheric StrokeCompletedNCT00840671Phase 3